Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter April 28, 2022

Low levels of G17 and Barrett esophagus: a clinical relationship

  • Francesco Di Mario ORCID logo EMAIL logo , Lorella Franzoni , Marilisa Franceschi , Kryssia Isabel Rodriguez-Castro , Michele Russo and Pellegrino Crafa ORCID logo

Corresponding author: Francesco Di Mario, Department of Medicine and Surgery, University of Parma, Parma, Italy, E-mail:

  1. Research funding: None declared.

  2. Author contribution: F. Di Mario and P. Crafa,: study design, writing of the manuscript, supervision. K. Rodriguez-Castro, M. Franceschi, M. Russo, L. Franzoni: clinical data collection and analysis of the literature. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The research had followed the tenets of the Helsinki Declaration and the study was performed following the declaration of Helsinki and approved by the local Ethics Committee (Identifier: 92687).


1. El-Serag, HB, Sweet, S, Winchester, CC, Dent, J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014;63:871–80. in Google Scholar

2. Spechler, SJ. Barrett´s esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy. Med Clin 2002;86:1423–45. in Google Scholar

3. Rodriguez-Castro, K, Crafa, P, Francheschi, M, Franzoni, L, Brozzi, L, Ferronato, A, et al.. Barrett’s esophagus: results from an Italian cohort with tight endoscopic surveillance. Acta Biomed 2022;93: e2022130. in Google Scholar PubMed PubMed Central

4. Hirschowitz, BI, Molina, E. Relation of gastric acid and pepsin secretion to gastrin levels in dogs given bombesin and gastrin-17. Am J Physiol 1983;244:G546–551. in Google Scholar PubMed

5. Muller, J, Kirchner, T, Muller-Hermelink, HK. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol 1987;11:909–17. in Google Scholar PubMed

6. Sipponen, P, Ranta, P, Helske, T, Kääriäinen, I, Mäki, T, Linnala, A, et al.. Serum level of amidated gastrin-17 and pepsinogen I in atrophic gastritis; an observational case-control study. Scand J Gastroenterol 2002;37:785–91. in Google Scholar

7. Malmström, J, Stadil, F. Gastrin content and gastrin release. Studies on the antral content of gastrin and its release to serum during stimulation by food. Scand J Gastroenterol 1976;37:71–6.Search in Google Scholar

8. Sipponen, P, Vauhkonen, M, Helske, T, Kaariainen, I. Harkonen M Low circulating levels of gastrin-17 in patients with Barrett’s esophagus. World J Gastroenterol 2005;11:5988–92. in Google Scholar PubMed PubMed Central

9. Di Mario, F, Crafa, P, Franceschi, M, Rodriguez-Castro, K, Baldassarre, G, Ferronato, A, et al.. Low levels of gastrin 17 are related with endoscopic findings of esophagitis and typical symptoms of GERD. J Gastrointestin Liver Dis 2021;30:25–9. in Google Scholar PubMed

10. Straathof, JW, Lamers, CB, Masclee, AA. Effect of gastrin-17 on lower esophageal sphincter characteristics in man. Dig Dis Sci 1997;42:2547–51. in Google Scholar

Received: 2022-04-14
Accepted: 2022-04-14
Published Online: 2022-04-28
Published in Print: 2022-06-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 25.9.2023 from
Scroll to top button